During busy hours, it might take up to 5-7 seconds to generate Research Reports after you have selected a stock.
Vertex Pharmaceuticals, Inc. VRTX: $268.1850 Northern Avenue, Boston, MA, US. | Sector: Health Technology | Exchange: NASDAQ | Web: http://www.vrtx.com
BOSTON--(BUSINESS WIRE)-- #ECFS2020--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that data from the company’s portfolio of cystic fibrosis (CF) medicines will be presented at th
Summary List Placement These days it's hard to picture a stock market that isn't dominated by Big Tech. But two decades ago, who imagined a market where GE and Exxon were almost afterthoughts? The amo
Also, Wall Street views on Sirius XM, Equinix, Aaron’s, Vertex Pharmaceuticals, IMAX, and First Republic Bank.
The allure of Autodesk, Intuitive Surgical, PayPal, Vertex Pharmaceuticals, ServiceNow, and some small-cap funds. Also, Blackstone boss Steve Schwarzman’s take on the future of cities.
The European Medicines Agency's advisory group CHMP has adopted a position opinion backing the use of Vertex Pharmaceuticals' (NASDAQ:VRTX) Kalydeco (ivaca
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) (the fir
Moderna (NASDAQ:MRNA) inks a research collaboration and licensing agreement with Vertex Pharmaceuticals (NASDAQ:VRTX) aimed at the discovery and developmen
NEW YORK, Sept. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DAL, SGMS, GME, VRTX, and FBIO. To see how InvestorsObserver's proprietary scoring system rates these s
The European Medicines Agency (EMA) has validated Vertex Pharmaceuticals' (NASDAQ:VRTX) Type II Variation Marketing Authorization Application for the expan
LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the European Medicines Agency (EMA) has validated a Type II Variation Marketing Authorization Application (M